A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

NCT00373256 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: Sunitinib
DRUG: paclitaxel
DRUG: bevacizumab
DRUG: paclitaxel

Sponsor

Pfizer